Enacted
SUPPORT for Patients and Communities Reauthorization Act of 2025
This legislation reauthorizes and increases federal funding through 2030 for nationwide addiction treatment, overdose prevention, mental health services, and recovery programs. It equips emergency responders with overdose-reversal medications, allows federal grant funds to cover drug-testing supplies like fentanyl strips where state law permits, and supports housing and job training for people in recovery. The bill also broadens who can provide required addiction training to prescribers, enables doctors to receive certain injectable addiction treatments directly from pharmacies, and mandates stronger cybersecurity safeguards for the 988 Suicide & Crisis Lifeline.
People affected—not determinable from the text provided
Fiscal magnitude$4.1Bprovisional · pending reviewSum of specific appropriations authorized across fiscal years 2026 through 2030 in sections 101 ($21.25M), 103(c) ($2.528B), 104(a) ($62.5M), 106 ($285M), 107(b) ($496.66M), 109 ($45M), 201 ($194.66M), 204 ($200M), 301 ($85M), 302 ($10M), 304 ($64M), and 305(a) ($60M). Full fiscal total is not determinable from the text because sections 102, 203, 303, 305(b), and 306 extend authorizations without naming dollar amounts.
Reach40provisional · pending reviewrigor: heuristic llm
What this bill touches.
Spending vs. restraint+35College cost & debt+15Substance use & mental health+60Drugs & enforcement+25
Who it helps · who it burdens.
Who it helps
- Substance use disorder treatment healthcare workersAuthorizes $40 million annually from fiscal years 2026 through 2030 for student loan repayments for clinicians and healthcare professionals providing substance use disorder care under Sec. 204.
- State and Tribal health agenciesPermits states and tribes to spend federal grant money on drug-checking supplies like fentanyl and xylazine test strips, and authorizes expanded federal grants for overdose surveillance, rapid response, and fetal alcohol spectrum disorders under Sec. 103, 104, and 113.
- First responders and emergency personnelExpands grant-funded training to cover medical responses to non-opioid drug overdoses in addition to opioid overdoses, authorizing $57 million each year through fiscal year 2030 under Sec. 106.
- Pharmacies and prescribing cliniciansAllows pharmacies to deliver schedule III, IV, or V controlled substances directly to prescribing clinicians for injection, implantation, or administration under certain safety monitoring programs under Sec. 401.
- State prescription drug monitoring program administratorsProtects state prescription drug monitoring programs from being required by federal health officials to use specific technology vendors or specific connection platforms beyond open standards under Sec. 105.
- Individuals in substance use disorder recoveryAuthorizes expanded funding for community recovery organizations, peer support networks, comprehensive recovery centers, transportation assistance for job training, and transitional recovery housing through fiscal year 2030 under Sec. 301, 302, 303, and 305.
- Pregnant and postpartum women with substance use disordersReauthorizes and increases funding to $38.93 million annually through fiscal year 2030 for residential treatment programs specifically tailored for pregnant and postpartum women under Sec. 201.
Who it burdens
- 988 Suicide and Crisis Lifeline network administrator and local crisis centersMust oversee technology, eliminate cybersecurity vulnerabilities, and report identified vulnerabilities and security incidents to federal regulators under Sec. 108.